Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Foghorn Therapeutics Inc.

2.00
+0.01000.50%
Post-market: 1.99-0.0100-0.50%19:30 EDT
Volume:646.95K
Turnover:1.31M
Market Cap:118.77M
PE:-2.05
High:2.08
Open:1.96
Low:1.95
Close:1.99
52wk High:7.61
52wk Low:1.79
Shares:59.39M
Float Shares:25.58M
Volume Ratio:0.49
T/O Rate:2.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9742
EPS(LYR):-1.1800
ROE:-470.38%
ROA:-19.92%
PB:-1.47
PE(LYR):-1.69

Loading ...

OverviewCompanyNewsFilings

Foghorn Therapeutics joins Stifel Virtual Targeted Oncology Forum lineup

Reuters
·
May 12

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences in May

GlobeNewswire
·
May 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 08

Analysts Offer Insights on Healthcare Companies: Foghorn Therapeutics (FHTX) and Monte Rosa Therapeutics (GLUE)

TIPRANKS
·
May 08

Foghorn Therapeutics Highlights Q1 Progress in Oncology Pipeline

TIPRANKS
·
May 07

Foghorn Therapeutics Q1 FY26 net loss widens to $19.9 million; revenue falls 45% to $3.3 million

Reuters
·
May 07

Foghorn Therapeutics Provides First Quarter 2026 Financial and Corporate Update

THOMSON REUTERS
·
May 07

Foghorn Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 30

Foghorn Highlights Preclinical Chromatin Oncology Advances at AACR

TIPRANKS
·
Apr 22

Foghorn reports preclinical data for SMARCA2 inhibitor FHD-909 in mouse models

Reuters
·
Apr 22

Analyst Rate

Buy
Buy
60.00%
Hold
40.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Pre-MKt
Financial Report Announcement
May 07, 2026 Pre-MKt
Financial Report Announcement
Mar 11, 2026 Post-Mkt
Financial Report Announcement
Nov 05, 2025 Pre-MKt
Financial Report Announcement
Aug 05, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.05
Current
-3.70
Sector Average
95.02%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.05
Maximum
-1.09
+1 STD
-2.34
Minimum
-9.13
-1 STD
-5.07
Average
-3.70

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.